Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ehrlich

Showing results (211-220 of 278) with videos related to

Pageof 28
Sort By:
Human Vaccines & Immunotherapeutics|June 16, 2012
Antibody persistence after two vaccinations with either FSME-IMMUN® Junior or ENCEPUR® Children followed by third vaccination with FSME-IMMUN® JuniorRoman Prymula, Eva Maria Pöllabauer, Borislava G Pavlova, et al.
AJR. American Journal of Roentgenology|February 27, 2019
Effect of Reader and Patient Parameters on the Performance of Last-Image-Hold for Fluoroscopic Grading of Vesicoureteric RefluxAli Y Mian, Ian P Mills, Alison D Sheridan, et al.
Journal of Virus Eradication|February 26, 2019
Safety, tolerability and impact on viral reservoirs of the addition to antiretroviral therapy of ABX464, an investigational antiviral drug, in individuals living with HIV-1: a Phase IIa randomised controlled studySofie Rutsaert, Jean-Marc Steens, Paul Gineste, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 11, 2007
Evaluation of pharmacokinetics, efficacy and safety of Immunate solvent detergent in previously treated patients with severe haemophilia AL Nemes, T Lissitchkov, A Klukowska, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 24, 2012
A cell culture-derived influenza vaccine provides consistent protection against infection and reduces the duration and severity of disease in infected individualsHartmut J Ehrlich, Julia Singer, Gregory Berezuk, et al.
The Journal of Infectious Diseases|November 18, 2011
A vero cell-derived whole-virus H5N1 vaccine effectively induces neuraminidase-inhibiting antibodiesRichard Fritz, Nicolas Sabarth, Stefan Kiermayr, et al.
Seminars in Thrombosis and Hemostasis|July 17, 2010
Structure and function of a recombinant von Willebrand factor drug candidatePeter L Turecek, Gerald Schrenk, Hanspeter Rottensteiner, et al.
Vaccine|April 21, 2006
Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN: results of two large phase 3 clinical studiesA Loew-Baselli, R Konior, B G Pavlova, et al.
Vaccine|December 17, 2011
Clinical development of a Vero cell culture-derived seasonal influenza vaccineHartmut J Ehrlich, Gregory Berezuk, Sandor Fritsch, et al.
Vox Sanguinis|October 16, 2010
Biochemical, molecular and preclinical characterization of a double-virus-reduced human butyrylcholinesterase preparation designed for clinical useA Weber, H Butterweck, U Mais-Paul, et al.
Pageof 28

Showing results (211-220 of 278) with videos related to

Sort By:
Pageof 28
Human Vaccines & Immunotherapeutics|June 16, 2012
Antibody persistence after two vaccinations with either FSME-IMMUN® Junior or ENCEPUR® Children followed by third vaccination with FSME-IMMUN® JuniorRoman Prymula, Eva Maria Pöllabauer, Borislava G Pavlova, et al.
AJR. American Journal of Roentgenology|February 27, 2019
Effect of Reader and Patient Parameters on the Performance of Last-Image-Hold for Fluoroscopic Grading of Vesicoureteric RefluxAli Y Mian, Ian P Mills, Alison D Sheridan, et al.
Journal of Virus Eradication|February 26, 2019
Safety, tolerability and impact on viral reservoirs of the addition to antiretroviral therapy of ABX464, an investigational antiviral drug, in individuals living with HIV-1: a Phase IIa randomised controlled studySofie Rutsaert, Jean-Marc Steens, Paul Gineste, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 11, 2007
Evaluation of pharmacokinetics, efficacy and safety of Immunate solvent detergent in previously treated patients with severe haemophilia AL Nemes, T Lissitchkov, A Klukowska, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 24, 2012
A cell culture-derived influenza vaccine provides consistent protection against infection and reduces the duration and severity of disease in infected individualsHartmut J Ehrlich, Julia Singer, Gregory Berezuk, et al.
The Journal of Infectious Diseases|November 18, 2011
A vero cell-derived whole-virus H5N1 vaccine effectively induces neuraminidase-inhibiting antibodiesRichard Fritz, Nicolas Sabarth, Stefan Kiermayr, et al.
Seminars in Thrombosis and Hemostasis|July 17, 2010
Structure and function of a recombinant von Willebrand factor drug candidatePeter L Turecek, Gerald Schrenk, Hanspeter Rottensteiner, et al.
Vaccine|April 21, 2006
Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN: results of two large phase 3 clinical studiesA Loew-Baselli, R Konior, B G Pavlova, et al.
Vaccine|December 17, 2011
Clinical development of a Vero cell culture-derived seasonal influenza vaccineHartmut J Ehrlich, Gregory Berezuk, Sandor Fritsch, et al.
Vox Sanguinis|October 16, 2010
Biochemical, molecular and preclinical characterization of a double-virus-reduced human butyrylcholinesterase preparation designed for clinical useA Weber, H Butterweck, U Mais-Paul, et al.
Pageof 28